Hearing impairment in patients with myotonic dystrophy type 2
Objective To systematically assess auditory characteristics of a large cohort of patients with genetically confirmed myotonic dystrophy type 2 (DM2). Methods Patients with DM2 were included prospectively in an international cross-sectional study. A structured interview about hearing symptoms was he...
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
American Academy of Neurology
2018
|
| _version_ | 1826257393732812800 |
|---|---|
| author | van Vliet, J Tieleman, AA van Engelen, BGM Bassez, G Servais, L Béhin, A Stojkovic, T Meulstee, J Engel, JAM Lamas, G Eymard, B Verhagen, WIM Mamelle, E |
| author_facet | van Vliet, J Tieleman, AA van Engelen, BGM Bassez, G Servais, L Béhin, A Stojkovic, T Meulstee, J Engel, JAM Lamas, G Eymard, B Verhagen, WIM Mamelle, E |
| author_sort | van Vliet, J |
| collection | OXFORD |
| description | Objective To systematically assess auditory characteristics of a large cohort of patients with genetically confirmed myotonic dystrophy type 2 (DM2).
Methods Patients with DM2 were included prospectively in an international cross-sectional study. A structured interview about hearing symptoms was held. Thereafter, standardized otologic examination, pure tone audiometry (PTA; 0.25, 0.5, 1, 2, 4, and 8 kHz), speech audiometry, tympanometry, acoustic middle ear muscle reflexes, and brainstem auditory evoked potentials (BAEP) were performed. The ISO 7029 standard was used to compare the PTA results with established hearing thresholds of the general population according to sex and age.
Results Thirty-one Dutch and 25 French patients with DM2 (61% female) were included with a mean age of 57 years (range 31–78). The median hearing threshold of the DM2 cohort was higher for all measured frequencies, compared to the 50th percentile of normal (p < 0.001). Hearing impairment was mild in 39%, moderate in 21%, and severe in 2% of patients with DM2. The absence of an air–bone gap with PTA, concordant results of speech audiometry with PTA, and normal findings of BAEP suggest that the sensorineural hearing impairment is located in the cochlea. A significant correlation was found between hearing impairment and age, even when corrected for presbycusis.
Conclusions Cochlear sensorineural hearing impairment is a frequent symptom in patients with DM2, suggesting an early presbycusis. Therefore, we recommend informing about hearing impairment and readily performing audiometry when hearing impairment is suspected in order to propose early hearing rehabilitation with hearing aids when indicated. |
| first_indexed | 2024-03-06T18:17:30Z |
| format | Journal article |
| id | oxford-uuid:051e23ef-26c5-4a80-a921-81c61e575ba3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:17:30Z |
| publishDate | 2018 |
| publisher | American Academy of Neurology |
| record_format | dspace |
| spelling | oxford-uuid:051e23ef-26c5-4a80-a921-81c61e575ba32022-03-26T08:55:25ZHearing impairment in patients with myotonic dystrophy type 2Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:051e23ef-26c5-4a80-a921-81c61e575ba3EnglishSymplectic ElementsAmerican Academy of Neurology2018van Vliet, JTieleman, AAvan Engelen, BGMBassez, GServais, LBéhin, AStojkovic, TMeulstee, JEngel, JAMLamas, GEymard, BVerhagen, WIMMamelle, EObjective To systematically assess auditory characteristics of a large cohort of patients with genetically confirmed myotonic dystrophy type 2 (DM2). Methods Patients with DM2 were included prospectively in an international cross-sectional study. A structured interview about hearing symptoms was held. Thereafter, standardized otologic examination, pure tone audiometry (PTA; 0.25, 0.5, 1, 2, 4, and 8 kHz), speech audiometry, tympanometry, acoustic middle ear muscle reflexes, and brainstem auditory evoked potentials (BAEP) were performed. The ISO 7029 standard was used to compare the PTA results with established hearing thresholds of the general population according to sex and age. Results Thirty-one Dutch and 25 French patients with DM2 (61% female) were included with a mean age of 57 years (range 31–78). The median hearing threshold of the DM2 cohort was higher for all measured frequencies, compared to the 50th percentile of normal (p < 0.001). Hearing impairment was mild in 39%, moderate in 21%, and severe in 2% of patients with DM2. The absence of an air–bone gap with PTA, concordant results of speech audiometry with PTA, and normal findings of BAEP suggest that the sensorineural hearing impairment is located in the cochlea. A significant correlation was found between hearing impairment and age, even when corrected for presbycusis. Conclusions Cochlear sensorineural hearing impairment is a frequent symptom in patients with DM2, suggesting an early presbycusis. Therefore, we recommend informing about hearing impairment and readily performing audiometry when hearing impairment is suspected in order to propose early hearing rehabilitation with hearing aids when indicated. |
| spellingShingle | van Vliet, J Tieleman, AA van Engelen, BGM Bassez, G Servais, L Béhin, A Stojkovic, T Meulstee, J Engel, JAM Lamas, G Eymard, B Verhagen, WIM Mamelle, E Hearing impairment in patients with myotonic dystrophy type 2 |
| title | Hearing impairment in patients with myotonic dystrophy type 2 |
| title_full | Hearing impairment in patients with myotonic dystrophy type 2 |
| title_fullStr | Hearing impairment in patients with myotonic dystrophy type 2 |
| title_full_unstemmed | Hearing impairment in patients with myotonic dystrophy type 2 |
| title_short | Hearing impairment in patients with myotonic dystrophy type 2 |
| title_sort | hearing impairment in patients with myotonic dystrophy type 2 |
| work_keys_str_mv | AT vanvlietj hearingimpairmentinpatientswithmyotonicdystrophytype2 AT tielemanaa hearingimpairmentinpatientswithmyotonicdystrophytype2 AT vanengelenbgm hearingimpairmentinpatientswithmyotonicdystrophytype2 AT bassezg hearingimpairmentinpatientswithmyotonicdystrophytype2 AT servaisl hearingimpairmentinpatientswithmyotonicdystrophytype2 AT behina hearingimpairmentinpatientswithmyotonicdystrophytype2 AT stojkovict hearingimpairmentinpatientswithmyotonicdystrophytype2 AT meulsteej hearingimpairmentinpatientswithmyotonicdystrophytype2 AT engeljam hearingimpairmentinpatientswithmyotonicdystrophytype2 AT lamasg hearingimpairmentinpatientswithmyotonicdystrophytype2 AT eymardb hearingimpairmentinpatientswithmyotonicdystrophytype2 AT verhagenwim hearingimpairmentinpatientswithmyotonicdystrophytype2 AT mamellee hearingimpairmentinpatientswithmyotonicdystrophytype2 |